- Home
- DSS
DSS
DSS Inc.
as 03-28-2025 4:00pm EST
DSS Inc is operating a business focused on Five operating segments Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. Currently operates five distinct business lines operate around the globe with primary operations in North America and Asia.
| Founded: | 1984 | Country: | United States |
| Employees: | N/A | City: | WEST HENRIETTA |
| Market Cap: | 7.3M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 78.8K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -9.12 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.77 - $2.30 | Next Earning Date: | 05-13-2025 |
| Revenue: | $25,019,000 | Revenue Growth: | -17.43% |
| Revenue Growth (this year): | -0.81% | Revenue Growth (next year): | N/A |
Latest DSS Inc. News
DSS Breaking Stock News: Dive into DSS Ticker-Specific Updates for Smart Investing
GlobeNewswire
a month ago
DSS, Inc. Announces Sale of Celios® to Impact BioMedical, Streamlining Portfolio for Strategic Growth
GlobeNewswire
2 months ago
DSS, Inc. Issues Letter to Shareholders
GlobeNewswire
6 months ago
DSS, Inc. Celebrates Impact BioMedical Inc.'s Successful IPO and Proudly Advances Shareholder Value
GlobeNewswire
7 months ago
AmericaFirst Funds Trust Announces Changes to Board of Trustees
GlobeNewswire
7 months ago
DSS, Inc. Names Jason Grady as Interim Chief Executive Officer
GlobeNewswire
a year ago
Impact Biomedical, Inc. Announces U.S. Patent Allowance of Laetose™ Technology Entitled "Low Glycemic Sugar Composition."
PR Newswire
a year ago
Allspring Closed-End Funds Declare Monthly Distributions
ACCESSWIRE
a year ago
GameSquare Officially Launches Moonlight Studios To Further Expand Its World-Building Division Led by Former Pro Fortnite Player
Compare DSS vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "DSS DSS Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.